KemPharma Cash Flow - Annual (NASDAQ:KMPH)

Add to My Stocks
$4.98 $0.13 (2.68%) KMPH stock closing price Sep 18, 2018 (Closing)

The KemPharma cash flow statement is one of the three reports that the company generates every quarter. This report provides details about cash inflows and outflows due to the company's business and investment activities, and summarize cash outflows for a given quarter. For KemPharma profits one has to check the income statement and for KemPharma debt one has to check the balance sheet. This statement can tell if a company is running out of money while still being profitable and is useful in KemPharma stock analysis. KemPharma had a negative net income cash flow of $-43.38M for the latest 2017. This report is very useful in measuring the short term viability of a company. The cash from operating activities for KemPharma is $ 2017, which saw a decrease from previous year.

View details of KemPharma cash flows for latest & last 10 financial years
show more
Fiscal year is Jan - Dec20172016201520142013
Net Income Cash Flow
-43.38M-16.51M-54.66M-24.45M-5.22M
Depreciation Depletion Amortization Cash-Flow1.89M1.79M1.99M1.18M1.62M
Net Increase (Decrease) in Assets Liabilities-1.65M3.32M-1.45M-
Cash From (used in) Discontinued Operations-----
Other Adjustments Net10.03M-18.36M32.31M7.13M-0.83M
Net Cash from (used by) Operating Activities
-33.1M-29.77M-20.26M-14.67M-4.31M
Increase (Decrease) in Prop Plant And Equipment-0.18M-0.64M-0.13M-0.04M-0.04M
Acquisition Disposition of Subsidiaires-----
Increase (Decrease) in Investments27.59M-45.2M-19M--
Other Cash Inflow (Outflow) from Investment Activities--1.1M---
Net Cash from (used by) Investment Activities
27.41M-46.94M-19.13M-0.04M-0.04M
Issuance (Purchase) of Equity Shares--64.34M--
Issuance (Repayment) of Debt Securities-0.15M62.16M-0.03M24.96M3.79M
Increase (Decrease) in Bank & Other Borrowings----0.03M-
Payment of Dividends & Other Cash Distributions-----
Other Cash from (used by) Financing Activities-0.05M-1.14M-2.84M-1.92M-
Net Cash from (used by) Financing Activities
-0.2M61.16M61.46M23M3.78M
Effect of Exchange Rate Changes on Cash-----
Net Change in Cash & Cash Equivalents
-5.89M-15.55M22.06M8.28M-0.57M
Cash & Equivalents at Beginning of Year17.86M32.31M10.25M1.96M2.54M
Cash & Equivalents at Year End11.97M16.76M32.31M10.25M1.96M
All figures in USD. M: Millions of USD, B: Billions of USD.

The statement of cash flows comprises of cash flow from financing, cash flow from operations and cash flow from investing activities. All the three can have an impact on the stock price. The KemPharma stock price history and KemPharma stock comparison chart inevitably reflect its cash flow situation.

  • Net Change in Cash and Cash Equivalents: A positive net change in cash and cash equivalents shows that KemPharma is able to meet its expenditure and grow cash at hand which demonstrates the financial strength of the company's balance sheet. Also see - KemPharma stock price movement.
  • Cash Flow from operating activities: KemPharma reported a negative operating cash flow of $-33.1M for 2017 and has seen a decrease from the previous year. Operating cash flow comes from main business activities. Investors look for positive cash flow from recurring operating activities.
  • Cash Flow from investment activities: This includes buying/selling of land and equipment, acquisitions and mergers, sell-off, investment in other companies like buying bonds, stocks etc., and was $27.41M for KMPH in last 2017 report.
  • Cash Flow from financing activities: The cash inflow/outflow from financing activities was $-0.2M for KemPharma. The money accounted for under this head comes from external sources which includes lenders, investors and shareholders. Positive cash flow is generated when the company gets cash because of issuance of stocks or bonds. Similarly negative cash flow is generated when shares are repurchased, dividend payments are made, and loans or interest on loans are paid back.

Key Financial Ratios For KemPharma Cash Flow